189 related articles for article (PubMed ID: 34425759)
1. Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model.
Kajiwara K; Sawa Y
BMC Nephrol; 2021 Aug; 22(1):287. PubMed ID: 34425759
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study for the expression of leukocyte adhesion molecules, and FGF23 and ACE2 in P. gingivalis LPS-induced diabetic nephropathy.
Kajiwara K; Sawa Y; Fujita T; Tamaoki S
BMC Nephrol; 2021 Jan; 22(1):3. PubMed ID: 33407253
[TBL] [Abstract][Full Text] [Related]
3. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.
Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292
[TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.
Sawa Y; Takata S; Hatakeyama Y; Ishikawa H; Tsuruga E
PLoS One; 2014; 9(5):e97165. PubMed ID: 24835775
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
Zhao S; Lo CS; Miyata KN; Ghosh A; Zhao XP; Chenier I; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Diabetes; 2021 Jun; 70(6):1388-1403. PubMed ID: 33820760
[TBL] [Abstract][Full Text] [Related]
6. The promotion of nephropathy by
Kajiwara K; Takata S; To TT; Takara K; Hatakeyama Y; Tamaoki S; Darveau RP; Ishikawa H; Sawa Y
Diabetol Metab Syndr; 2017; 9():73. PubMed ID: 29018490
[TBL] [Abstract][Full Text] [Related]
7. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.
Wang XX; Levi J; Luo Y; Myakala K; Herman-Edelstein M; Qiu L; Wang D; Peng Y; Grenz A; Lucia S; Dobrinskikh E; D'Agati VD; Koepsell H; Kopp JB; Rosenberg AZ; Levi M
J Biol Chem; 2017 Mar; 292(13):5335-5348. PubMed ID: 28196866
[TBL] [Abstract][Full Text] [Related]
9. Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.
Freitas HS; Anhê GF; Melo KF; Okamoto MM; Oliveira-Souza M; Bordin S; Machado UF
Endocrinology; 2008 Feb; 149(2):717-24. PubMed ID: 17962340
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.
Wada J; Zhang H; Tsuchiyama Y; Hiragushi K; Hida K; Shikata K; Kanwar YS; Makino H
Kidney Int; 2001 Apr; 59(4):1363-73. PubMed ID: 11260397
[TBL] [Abstract][Full Text] [Related]
11. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes.
Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Chattipakorn SC; Chattipakorn N; Lungkaphin A
Biomed Pharmacother; 2017 Oct; 94():176-187. PubMed ID: 28759755
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
Kitada K; Nakano D; Ohsaki H; Hitomi H; Minamino T; Yatabe J; Felder RA; Mori H; Masaki T; Kobori H; Nishiyama A
J Diabetes Complications; 2014; 28(5):604-11. PubMed ID: 24996978
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats.
Osorio H; Coronel I; Arellano A; Franco M; Escalante B; Bautista R
Diabetes Res Clin Pract; 2012 Aug; 97(2):276-82. PubMed ID: 22429686
[TBL] [Abstract][Full Text] [Related]
14. High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection.
Umino H; Hasegawa K; Minakuchi H; Muraoka H; Kawaguchi T; Kanda T; Tokuyama H; Wakino S; Itoh H
Sci Rep; 2018 May; 8(1):6791. PubMed ID: 29717156
[TBL] [Abstract][Full Text] [Related]
15. Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.
Tahara A; Takasu T
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):395-406. PubMed ID: 29374293
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
[TBL] [Abstract][Full Text] [Related]
17. Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.
Brouwers B; Pruniau VPEG; Cauwelier EJG; Schuit F; Lerut E; Ectors N; Declercq J; Creemers JWM
J Biol Chem; 2013 Sep; 288(38):27200-27207. PubMed ID: 23940028
[TBL] [Abstract][Full Text] [Related]
18. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
19. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
20. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
